跳至主要内容
临床试验/RBR-6qgc6m
RBR-6qgc6m进行中(未招募)4 期

Influence of genotype of cytochrome P450 (CYP2C9) on clinical efficacy and pharmacokinetics of Piroxicam after lower third molar surgery - : Influence of CYP2C9 on clinical efficacy Piroxicam after third molar surgeries

Faculdade de Odontologia de Bauru0 个研究点开始时间: 2019年11月13日最近更新:
适应症

试验速览

阶段
4 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 60Y(—)

入选标准

  • Healthy volunteers of both genders; between 18 and 60 years; are not making use of nonsteroidal anti-inflammatory drugs in the last 7 days.

排除标准

  • Local anesthetics allergy, history of gastrointestinal bleeding or ulcers; kidney disease; asthma; allergy or sensitivity to aspirin or any other anti-inflammatory non-steroid agent; pregnant or nursing women; patients using antidepressant; diuretic or aspirin; patients received antibiotics for 30 days prior to surgery.

研究者

发起方
Faculdade de Odontologia de Bauru

相似试验